|Presidential Keynote Symposium|
Presidential Keynote Symposium – Wednesday, March 8, 2017; 5:00 p.m. – 6:00 p.m.
Title: Nicotine + other addictive behaviors: Addressing the Added Complexities across the Translational Continuum
Chairs: Maciej L. Goniewicz, PhD, Roswell Park Cancer Institute, USA and Rachel Grana Mayne, PhD, National Cancer Institute, USA
Presenters: Joanna E Cohen, PhD, Director, Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public, Baltimore, USA; Neal L Benowitz MD, Chief, Division of Clinical Pharmacology, University of California San Francisco, USA; Robert West, PhD, Professor of Health Psychology, University College London, UK; Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Australia; Judith J. Prochaska, PhD, MPH, Associate Professor of Medicine, Department of Medicine, Stanford University, USA
Whilst the overall prevalence of smoking is decreasing in many countries, a significant proportion of tobacco smokers also use various psychoactive substances. Smoking rates are high among those who are addicted to various legal and illegal drugs, including marijuana, alcohol, and opioids. These populations need to be a focus of tobacco control policies and interventions moving forward, so that ‘no man is left behind’ in our efforts to reduce smoking prevalence. During this symposium, we will address the added complexities of nicotine and other addictive behaviors across the translational continuum. First, Dr Cohen will present the scope of use of other drugs by tobacco users, and use of tobacco by users of other drugs. Dr Benowitz will review pharmacokinetic and pharmacodynamics interactions between nicotine and alcohol, cannabis, opiates and stimulants. Dr West will show how a general model of behavior can provide a framework for understanding patterns of association with addictive disorders and how this can be used to guide interventions to combat cigarette addiction in people who also suffer from other addictions. The public health challenge is to develop a framework that leads to the least harmful use of the least harmful products or mix of products. Dr Borland will discuss how tobacco smoking and nicotine fit into that agenda. Dr Prochaska will present new data and review the literature on treating tobacco addiction in smokers with co-occurring alcohol and other drug use disorders.